| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2023 ( Subtotal = $2,603,484 ) |
| 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | NU65PS923739 | Comprehensive High-Impact HIV Prevention Program for Young Men of Color Who Have Sex with Men | 00 | 2 | CDC | 3/3/2023 | $400,000 |
| 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | H7600177 | OP EARLY INTERVENTION SVCS W/RESPECT TO HIV DISEASE | 00 | 26 | HRSA | 3/15/2023 | $584,201 |
| 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R13HD113341 | Defining Research and Care in Diabetes in Pregnancy | 000 | 1 | NIH | 8/14/2023 | $10,000 |
| 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU65PS923739 | Comprehensive High-Impact HIV Prevention Program for Young Men of Color Who Have Sex with Men | 01 | 2 | CDC | 6/1/2023 | $0 |
| 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 00 | 3 | CDC | 6/2/2023 | $441,625 |
| 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R01HL154768 | The optimal loop diuretic: mechanistic insights from longitudinal changes in blood and urine proteins to explain efficacy and safety of torsemide vs furosemide after a heart failure hospitalization | 000 | 4 | NIH | 9/1/2023 | $387,840 |
| 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | K23HL153771 | Frailty and Resiliency in Older Adults with Acute Myocardial Infarction | 000 | 4 | NIH | 7/24/2023 | $183,120 |
| 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R18FD006920 | The Heart Failure Collaboratory Public-Private Partnership Between the United States Food and Drug Administration, the Inova Heart and Vascular Institute, and the Heart Failure Community | 001 | 4 | FDA | 4/5/2023 | $0 |
| 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | K23HL143179 | MicroRNA Biomarkers of Allograft Rejection and Cardiac Allograft Vasculopathy in Cardiac Transplantation | 000 | 4 | NIH | 6/16/2023 | $184,680 |
| 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | H1224873 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 00 | 11 | HRSA | 7/3/2023 | $585,866 |
| 2023 | 2022 | Inova Health Care Services | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 01 | 2 | CDC | 2/2/2023 | $0 |
| 2023 | 2022 | INOVA HEALTH CARE SERVICES | 8110 GATEHOUSE RD STE 200E | FALLS CHURCH | VA | 22042-1210 | FAIRFAX | USA | H7600177 | OP EARLY INTERVENTION SVCS W/RESPECT TO HIV DISEASE | 02 | 25 | HRSA | 11/2/2022 | $0 |
| 2023 | 2022 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22042-4868 | | USA | H1224873 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 01 | 10 | HRSA | 10/24/2022 | $0 |
| 2023 | 2022 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU65PS923739 | Comprehensive High-Impact HIV Prevention Program for Young Men of Color Who Have Sex with Men | 01 | 2 | CDC | 6/1/2023 | $0 |
| 2023 | 2022 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 00 | 3 | CDC | 6/2/2023 | $0 |
| 2023 | 2022 | INOVA HEALTH CARE SERVICES | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | NU65PS923739 | Comprehensive High-Impact HIV Prevention Program for Young Men of Color Who Have Sex with Men | 00 | 2 | CDC | 3/3/2023 | $0 |
| 2023 | 2021 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 00 | 3 | CDC | 6/2/2023 | $0 |
| 2023 | 2021 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R18FD006920 | The Heart Failure Collaboratory Public-Private Partnership Between the United States Food and Drug Administration, the Inova Heart and Vascular Institute, and the Heart Failure Community | 000 | 2 | FDA | 12/19/2022 | $0 |
| 2023 | 2021 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | H1224873 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 02 | 9 | HRSA | 6/28/2023 | -$119,959 |
| 2023 | 2021 | Inova Health Care Services | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 01 | 2 | CDC | 2/2/2023 | $0 |
| 2023 | 2020 | INOVA HEALTH CARE SERVICES | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | H7C37331 | Ryan White HIV/AIDS Program Part C EIS COVID-19 Response | 03 | 1 | HRSA | 4/14/2023 | $0 |
| 2023 | 2020 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R01CA194783 | Computational modeling of tumor burden by CT to advance cancer therapeutics | 000 | 6 | NIH | 10/11/2022 | -$53,889 |
|
 | Issue Date FY: 2022 ( Subtotal = $2,663,003 ) |
| 2022 | 2022 | Inova Health Care Services | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | H1224873 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 00 | 10 | HRSA | 7/8/2022 | $585,866 |
| 2022 | 2022 | INOVA HEALTH CARE SERVICES | 8110 GATEHOUSE RD STE 200E | FALLS CHURCH | VA | 22042-1210 | FAIRFAX | USA | R18FD006920 | The Heart Failure Collaboratory Public-Private Partnership Between the United States Food and Drug Administration, the Inova Heart and Vascular Institute, and the Heart Failure Community | 001 | 3 | FDA | 3/30/2022 | $0 |
| 2022 | 2022 | INOVA HEALTH CARE SERVICES | 8110 GATEHOUSE RD STE 200E | FALLS CHURCH | VA | 22042-1210 | FAIRFAX | USA | R18FD006920 | The Heart Failure Collaboratory Public-Private Partnership Between the United States Food and Drug Administration, the Inova Heart and Vascular Institute, and the Heart Failure Community | 000 | 3 | FDA | 3/23/2022 | $0 |
| 2022 | 2022 | INOVA HEALTH CARE SERVICES | 8110 GATEHOUSE RD STE 200E | FALLS CHURCH | VA | 22042-1210 | FAIRFAX | USA | R01HL154768 | The optimal loop diuretic: mechanistic insights from longitudinal changes in blood and urine proteins to explain efficacy and safety of torsemide vs furosemide after a heart failure hospitalization | 002 | 3 | NIH | 8/13/2022 | $388,080 |
| 2022 | 2022 | Inova Health Care Services | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | NU65PS923739 | Comprehensive High-Impact HIV Prevention Program for Young Men of Color Who Have Sex with Men | 01 | 1 | CDC | 6/23/2022 | $0 |
| 2022 | 2022 | Inova Health Care Services | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | NU65PS923739 | Comprehensive High-Impact HIV Prevention Program for Young Men of Color Who Have Sex with Men | 00 | 1 | CDC | 3/23/2022 | $400,000 |
| 2022 | 2022 | INOVA HEALTH CARE SERVICES | 8110 GATEHOUSE RD STE 200E | FALLS CHURCH | VA | 22042-1210 | FAIRFAX | USA | K23HL143179 | MicroRNA Biomarkers of Allograft Rejection and Cardiac Allograft Vasculopathy in Cardiac Transplantation | 000 | 3 | NIH | 6/6/2022 | $185,760 |
| 2022 | 2022 | Inova Health Care Services | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 00 | 2 | CDC | 6/17/2022 | $441,625 |
| 2022 | 2022 | Inova Health Care Services | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | H7600177 | OP EARLY INTERVENTION SVCS W/RESPECT TO HIV DISEASE | 01 | 25 | HRSA | 7/8/2022 | $438,151 |
| 2022 | 2022 | Inova Health Care Services | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | H7600177 | OP EARLY INTERVENTION SVCS W/RESPECT TO HIV DISEASE | 00 | 25 | HRSA | 3/24/2022 | $146,050 |
| 2022 | 2022 | INOVA HEALTH CARE SERVICES | 8110 GATEHOUSE RD STE 200E | FALLS CHURCH | VA | 22042-1210 | FAIRFAX | USA | K23HL153771 | Frailty and Resiliency in Older Adults with Acute Myocardial Infarction | 000 | 3 | NIH | 6/24/2022 | $183,120 |
| 2022 | 2021 | INOVA HEALTH CARE SERVICES | 8110 GATEHOUSE RD STE 200E | FALLS CHURCH | VA | 22042-1210 | FAIRFAX | USA | R01HL154768 | The optimal loop diuretic: mechanistic insights from longitudinal changes in blood and urine proteins to explain efficacy and safety of torsemide vs furosemide after a heart failure hospitalization | 000 | 2 | NIH | 12/16/2021 | $0 |
| 2022 | 2021 | INOVA HEALTH CARE SERVICES | 8110 GATEHOUSE RD STE 200E | FALLS CHURCH | VA | 22042-1210 | FAIRFAX | USA | R01HL154768 | The optimal loop diuretic: mechanistic insights from longitudinal changes in blood and urine proteins to explain efficacy and safety of torsemide vs furosemide after a heart failure hospitalization | 001 | 2 | NIH | 2/18/2022 | $0 |
| 2022 | 2021 | Inova Health Care Services | 8110 GATEHOUSE RD STE 200E | FALLS CHURCH | VA | 22042-1210 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 01 | 1 | CDC | 11/5/2021 | $0 |
| 2022 | 2021 | Inova Health Care Services | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 00 | 2 | CDC | 6/17/2022 | $0 |
| 2022 | 2021 | INOVA HEALTH CARE SERVICES | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | H7600177 | OP EARLY INTERVENTION SVCS W/RESPECT TO HIV DISEASE | 02 | 24 | HRSA | 8/25/2022 | $0 |
| 2022 | 2021 | Inova Health Care Services | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | H1224873 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 01 | 9 | HRSA | 10/22/2021 | $0 |
| 2022 | 2021 | INOVA HEALTH CARE SERVICES | 8110 GATEHOUSE RD STE 200E | FALLS CHURCH | VA | 22042-1210 | FAIRFAX | USA | K23HD099240 | The contribution of antibiotic exposure in the prenatal, peripartum and infancy period to intestinal microbiome perturbations and association with early childhood obesity. | 000 | 3 | NIH | 2/28/2022 | -$105,649 |
| 2022 | 2020 | Inova Health Care Services | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | H1X37050 | Ryan White HIV/AIDS Program Part D WICY COVID-19 Response | 03 | 1 | HRSA | 7/19/2022 | $0 |
|
 | Issue Date FY: 2021 ( Subtotal = $2,986,266 ) (Continued on the next page) |
| 2021 | 2021 | INOVA HEALTH CARE SERVICES | 8110 GATEHOUSE RD STE 200E | FALLS CHURCH | VA | 22042-1210 | FAIRFAX | USA | K23HD099240 | The contribution of antibiotic exposure in the prenatal, peripartum and infancy period to intestinal microbiome perturbations and association with early childhood obesity. | 001 | 3 | NIH | 8/24/2021 | $0 |
| 2021 | 2021 | INOVA HEALTH CARE SERVICES | 8110 GATEHOUSE RD STE 200E | FALLS CHURCH | VA | 22042-1210 | FAIRFAX | USA | K23HL143179 | MicroRNA Biomarkers of Allograft Rejection and Cardiac Allograft Vasculopathy in Cardiac Transplantation | 000 | 2 | NIH | 7/7/2021 | $185,760 |
| 2021 | 2021 | Inova Health Care Services | 8110 GATEHOUSE RD STE 200E | FALLS CHURCH | VA | 22042-1210 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 00 | 1 | CDC | 6/24/2021 | $441,625 |
| 2021 | 2021 | Inova Health Care Services | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | H7600177 | OP EARLY INTERVENTION SVCS W/RESPECT TO HIV DISEASE | 01 | 24 | HRSA | 9/21/2021 | $0 |
| 2021 | 2021 | Inova Health Care Services | 8110 GATEHOUSE RD STE 200E | FALLS CHURCH | VA | 22042-1210 | FAIRFAX | USA | H7600177 | OP EARLY INTERVENTION SVCS W/RESPECT TO HIV DISEASE | 00 | 24 | HRSA | 4/30/2021 | $556,122 |
| 2021 | 2021 | Inova Health Care Services | 8110 GATEHOUSE RD STE 200E | FALLS CHURCH | VA | 22042-1210 | FAIRFAX | USA | H1224873 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 00 | 9 | HRSA | 7/30/2021 | $561,875 |
|